2e Creative joins Fishawack Group

2e Creative, a healthcare marketing strategy firm focused on launching pharmaceutical and medical device products, has joined the Fishawack Group.

The deal follows on from 2e Creative receiving investment from the Fishawack Group. This partnership is particularly notable for 2eCreative, as it follows the agency’s inclusion in MM&M’s Top 100 Healthcare Agencies worldwide and three consecutive victories (2015, 2016, 2017) as MM&M Healthcare Agency of the Year.

“2e has been on an exhilarating growth trajectory for the past several years,” said Ross Toohey, CEO, 2eCreative.

“We chose Fishawack over a host of other potential investors because its global footprint, expansive capabilities and entrepreneurial culture represented the greatest advantage for our employees and clients. This is truly the next evolutionary leap for 2e and the brands we serve,” he added.

2e CEO Toohey shares news with team at 2e Creative

Fishawack is a global healthcare communications group with offices in London, Oxford, Brighton and Manchester in the UK, as well as Philadelphia, New York and San Diego in the US. The addition of 2e Creatjve will see Fishawack expand in the US, as the firm has operations in Missouri, Indiana, Texas and California. Following this partnership, the Fishawack Group now boasts over 750 employees worldwide, making it among the largest independent healthcare agencies globally.

“Fishawack is one of the new generation of leaders in healthcare communications. We’re challenging the major agency networks by fostering a uniquely collaborative culture across our agency collective,” said Oliver Dennis, CEO, Fishawack.

“We’re excited about 2e’s portfolio, capabilities and brilliant people. Ross has built a great entrepreneurial culture and we can’t wait to work with the 2e team,” he added.

Advisors to Fishawack included KPMG, Addleshaw Goddard LLP, and financial backers LDC and LGT Capital Partners. 2e’s advisors included Results International, Stoll Keenon Ogden PLLC and Clifton Larson Allen.